← Eichor
Condition: Interleukin Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Interleukin

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Apneic Oxygenation of the Non-ventilated Lung During Lung Cancer Surgery.
NA · 1 location(s) · Osijek University Hospital · NCT07393490The Effect of Anti-IL17 on Airway Hyperresponsiveness and Resistance
Phase N/A · 1 location(s) · Copenhagen University Hospital, Hvidovre · NCT06224634Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory
Phase 1 · 2 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT03721068A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Phase 1/Phase 2 · 19 location(s) · Nkarta, Inc. · NCT06557265Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06792487Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye
Phase 4 · 4 location(s) · Universiti Sains Malaysia · NCT07396441Thread Embedding Plus Auricular Acupressure for Non-Organic Insomnia Based on Traditional Medicine Pattern Differentiati
NA · 1 location(s) · University of Medicine and Pharmacy at Ho Chi Minh City · NCT07552714A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06287528Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06974877Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Phase 1 · 1 location(s) · VLP Therapeutics · NCT06736379Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients
Phase N/A · 1 location(s) · University Hospital Hradec Kralove · NCT04887623A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00091871Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair
Phase 4 · 1 location(s) · University of Crete · NCT04894864Tear Interleukin Biomarkers After Glaucoma Treatment
NA · 1 location(s) · Kazakh Eye Research Institute · NCT07592988The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breas
NA · 1 location(s) · Moscow Clinical Scientific Center · NCT04800393Neutralizing Interleukin (IL)-6
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07493317Low Dose IL-2 for the Treatment of Crohn's Disease
Phase 1/Phase 2 · 3 location(s) · Boston Children's Hospital · NCT04263831Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05153070Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.
Phase 1 · 2 location(s) · West China Hospital · NCT07040943Clazakizumab vs. Placebo - COVID-19 Infection
Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT04494724A Clinical Trial Evaluating IL-22BP/LNP Compound in Refractory Malignant Solid Tumors for Safety, Tolerability and Activ
Phase 1 · 1 location(s) · Xingchen Peng · NCT07100210Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Ass
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06052618Comparison Between Interleukin 6 and Procalcitonin in Detecting Sepsis and Incidence of Mortality in Burn ICU Patients
NA · 1 location(s) · Ain Shams University · NCT06915974NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Sub
Phase 1 · 1 location(s) · Washington University School of Medicine · NCT07052305Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
Phase 1/Phase 2 · 26 location(s) · Sanofi · NCT04643002Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety
Phase 4 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT07216014Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)
Phase N/A · 3 location(s) · Jonathan Krygier · NCT07234838Interleukin23 in Systemic Lupus
NA · 2 location(s) · Sohag University · NCT06713187International Rare And Severe Psoriasis Expert Network
Phase N/A · 8 location(s) · University Hospital, Basel, Switzerland · NCT04359394LONGITUDINAL FOLLOW-UP STUDY TO DETERMINE THE PREDICTIVE ABILITY OF A PANEL OF BIOMARKERS IN SALIVA IN HEALTHY AND PERIO
Phase N/A · 2 location(s) · Universidad Complutense de Madrid · NCT07167771
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.